Van ECK Associates Corp Sells 30,833 Shares of Bath & Body Works, Inc. (NYSE:BBWI)

Van ECK Associates Corp decreased its holdings in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 35.1% in the fourth quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor owned 57,003 shares of the company's stock after selling 30,833 shares during the quarter. Van ECK Associates Corp's holdings in Bath & Body Works were worth $2,460,000 as of its most recent filing with the SEC.

A number of other hedge funds and other institutional investors also recently made changes to their positions in BBWI. Commonwealth Equity Services LLC lifted its position in shares of Bath & Body Works by 3.3% during the 3rd quarter. Commonwealth Equity Services LLC now owns 11,044 shares of the company's stock worth $373,000 after buying an additional 348 shares during the period. Raymond James & Associates grew its holdings in shares of Bath & Body Works by 1,063.4% in the 3rd quarter. Raymond James & Associates now owns 103,099 shares of the company's stock worth $3,485,000 after purchasing an additional 94,237 shares during the last quarter. Forsta AP Fonden increased its position in shares of Bath & Body Works by 13.4% during the 3rd quarter. Forsta AP Fonden now owns 63,300 shares of the company's stock worth $2,140,000 after purchasing an additional 7,500 shares in the last quarter. New York State Teachers Retirement System lifted its holdings in Bath & Body Works by 3.6% during the 3rd quarter. New York State Teachers Retirement System now owns 241,567 shares of the company's stock valued at $8,165,000 after purchasing an additional 8,362 shares during the last quarter. Finally, Mirae Asset Global Investments Co. Ltd. boosted its position in Bath & Body Works by 3.2% in the third quarter. Mirae Asset Global Investments Co. Ltd. now owns 31,138 shares of the company's stock valued at $1,052,000 after buying an additional 955 shares in the last quarter. 95.14% of the stock is owned by institutional investors.

Wall Street Analyst Weigh In

A number of research firms have recently issued reports on BBWI. Telsey Advisory Group reiterated an "outperform" rating and issued a $53.00 target price on shares of Bath & Body Works in a research note on Friday, April 5th. BMO Capital Markets lifted their price target on Bath & Body Works from $48.00 to $50.00 and gave the company an "outperform" rating in a report on Friday, March 1st. Piper Sandler increased their price objective on shares of Bath & Body Works from $44.00 to $45.00 and gave the stock a "neutral" rating in a report on Tuesday, April 9th. The Goldman Sachs Group raised their price target on shares of Bath & Body Works from $49.00 to $56.00 and gave the company a "buy" rating in a report on Monday, March 4th. Finally, TD Cowen increased their price objective on Bath & Body Works from $35.00 to $55.00 and gave the company an "outperform" rating in a research report on Friday, March 1st. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and six have issued a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus price target of $46.73.

Insider Transactions at Bath & Body Works

In other Bath & Body Works news, insider Thomas E. Mazurek sold 4,285 shares of the stock in a transaction dated Wednesday, March 27th. The stock was sold at an average price of $48.89, for a total transaction of $209,493.65. Following the completion of the transaction, the insider now owns 45,992 shares in the company, valued at approximately $2,248,548.88. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. 0.19% of the stock is owned by insiders.

Bath & Body Works Trading Up 0.8 %

Shares of BBWI stock traded up $0.40 on Wednesday, hitting $47.62. The stock had a trading volume of 2,111,796 shares, compared to its average volume of 2,734,754. The firm has a market cap of $10.71 billion, a P/E ratio of 12.30, a PEG ratio of 1.49 and a beta of 1.89. Bath & Body Works, Inc. has a twelve month low of $27.30 and a twelve month high of $50.34. The company has a fifty day moving average price of $46.08 and a two-hundred day moving average price of $41.38.

Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its earnings results on Thursday, February 29th. The company reported $2.06 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $1.85 by $0.21. Bath & Body Works had a negative return on equity of 37.01% and a net margin of 11.82%. The firm had revenue of $2.91 billion during the quarter, compared to analysts' expectations of $2.84 billion. During the same period in the previous year, the firm earned $1.86 earnings per share. The company's revenue was up .8% on a year-over-year basis. On average, analysts expect that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, March 8th. Stockholders of record on Friday, February 23rd were issued a $0.20 dividend. This represents a $0.80 annualized dividend and a dividend yield of 1.68%. The ex-dividend date was Thursday, February 22nd. Bath & Body Works's dividend payout ratio (DPR) is presently 20.78%.

Bath & Body Works Profile

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.